LC-MS/MS analysis of plasma polyunsaturated fatty acids in type 2 diabetic patients after insulin analog initiation therapy
Open Access
- 6 November 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Lipids in Health and Disease
- Vol. 12 (1), 169
- https://doi.org/10.1186/1476-511x-12-169
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Effect of insulin analog initiation therapy on LDL/HDL subfraction profile and HDL associated enzymes in type 2 diabetic patientsLipids in Health and Disease, 2013
- The Effect of High-Dose Insulin Analog Initiation Therapy on Lipid Peroxidation Products and Oxidative Stress Markers in Type 2 Diabetic PatientsOxidative Medicine and Cellular Longevity, 2013
- The Use of ω-3 Poly-Unsaturated Fatty Acids in Heart Failure: A Preferential Role in Patients with DiabetesCardiovascular Drugs and Therapy, 2012
- Resolution of inflammation: therapeutic potential of pro-resolving lipids in type 2 diabetes mellitus and associated renal complicationsFrontiers in Immunology, 2012
- Obesity‐induced insulin resistance and hepatic steatosis are alleviated by ω‐3 fatty acids: a role for resolvins and protectinsThe FASEB Journal, 2009
- Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediatorsNature Reviews Immunology, 2008
- The Role of Inflammatory Cytokines in Diabetic NephropathyJournal of the American Society of Nephrology, 2008
- Polyunsaturated fatty acids in plasma and erythrocyte membrane lipids of diabetic childrenProstaglandins, Leukotrienes & Essential Fatty Acids, 2002
- Effects of Diabetes and Insulin on Hepatic Δ6 Desaturase Gene ExpressionBiochemical and Biophysical Research Communications, 2001
- Depression of microsomal desaturation of linoleictoy-linolenicacid in the alloxan-diabetic ratBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1966